HXN-1012

N/A

Report date: 2026/03/19 15:53:17

Base Information

Drug NameHXN-1012
Drug Alias NameHXN-1012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Thymic stromal lymphopoietinAnti-IL13
TargetsThymic stromal lymphopoietinInterleukin-13
Therapy Area/IndicationsSkin DiseasesPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesHelixon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHelixon LtdEarendil Labs
Inactive CompaniesN/A
Active IndicationsSkin DiseasesPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A